JP2010523102A5

JP2010523102A5 -

Download PDF

Info

Publication number: JP2010523102A5
Authority: JP; Japan
Prior art keywords: protein; activity; modified; cell; glycosylation
Prior art date: 2008-04-03
Legal status : Granted

Application number

JP2010501617A

Other languages

English (en)

Japanese (ja)

Other versions

JP2010523102A (ja

JP5967861B2 (ja

Filing date

2008-04-03

Publication date

2011-05-19

2008-04-03 Application filed filed Critical

2008-04-03 Priority claimed from PCT/IB2008/001814 external-priority patent/WO2008120107A2/en

2010-07-15 Publication of JP2010523102A publication Critical patent/JP2010523102A/ja

2011-05-19 Publication of JP2010523102A5 publication Critical patent/JP2010523102A5/ja

2016-08-10 Application granted granted Critical

2016-08-10 Publication of JP5967861B2 publication Critical patent/JP5967861B2/ja

Status Expired - Fee Related legal-status Critical Current

2028-04-03 Anticipated expiration legal-status Critical

Links

108090000623 proteins and genes Proteins 0.000 claims description 525
102000004169 proteins and genes Human genes 0.000 claims description 424
210000004027 cell Anatomy 0.000 claims description 399
230000000694 effects Effects 0.000 claims description 293
230000004988 N-glycosylation Effects 0.000 claims description 220
238000000034 method Methods 0.000 claims description 211
241000235015 Yarrowia lipolytica Species 0.000 claims description 110
230000014509 gene expression Effects 0.000 claims description 109
150000007523 nucleic acids Chemical class 0.000 claims description 108
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 94
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims description 94
OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 claims description 93
241000282414 Homo sapiens Species 0.000 claims description 82
239000012634 fragment Substances 0.000 claims description 77
108020004707 nucleic acids Proteins 0.000 claims description 76
102000039446 nucleic acids Human genes 0.000 claims description 76
125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 65
102100032086 Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase Human genes 0.000 claims description 57
101000776319 Homo sapiens Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase Proteins 0.000 claims description 57
239000013598 vector Substances 0.000 claims description 47
108010029607 4-nitrophenyl-alpha-glucosidase Proteins 0.000 claims description 45
102000003886 Glycoproteins Human genes 0.000 claims description 44
108090000288 Glycoproteins Proteins 0.000 claims description 44
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 42
239000002773 nucleotide Substances 0.000 claims description 42
230000004048 modification Effects 0.000 claims description 41
238000012986 modification Methods 0.000 claims description 41
125000003729 nucleotide group Chemical group 0.000 claims description 41
201000010099 disease Diseases 0.000 claims description 36
238000006206 glycosylation reaction Methods 0.000 claims description 35
108090000765 processed proteins & peptides Proteins 0.000 claims description 35
108091028043 Nucleic acid sequence Proteins 0.000 claims description 34
230000013595 glycosylation Effects 0.000 claims description 34
238000011282 treatment Methods 0.000 claims description 34
239000013604 expression vector Substances 0.000 claims description 31
102100039059 Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Human genes 0.000 claims description 28
101000958975 Homo sapiens Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Proteins 0.000 claims description 28
238000006366 phosphorylation reaction Methods 0.000 claims description 28
208000015439 Lysosomal storage disease Diseases 0.000 claims description 27
230000026731 phosphorylation Effects 0.000 claims description 27
229920001184 polypeptide Polymers 0.000 claims description 26
102000004196 processed proteins & peptides Human genes 0.000 claims description 26
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 25
238000012545 processing Methods 0.000 claims description 25
102000001696 Mannosidases Human genes 0.000 claims description 24
108010054377 Mannosidases Proteins 0.000 claims description 24
108010012864 alpha-Mannosidase Proteins 0.000 claims description 24
102000019199 alpha-Mannosidase Human genes 0.000 claims description 24
208000030159 metabolic disease Diseases 0.000 claims description 24
101150061302 och1 gene Proteins 0.000 claims description 24
-1 alpha-L-mannosidase Proteins 0.000 claims description 22
241000680806 Blastobotrys adeninivorans Species 0.000 claims description 21
OSKIPPQETUTOMW-YHLOVPAPSA-N N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2R,3S,4S,5R,6R)-4-[(2R,3S,4S,5S,6R)-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5R,6R)-6-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 OSKIPPQETUTOMW-YHLOVPAPSA-N 0.000 claims description 21
108020001507 fusion proteins Proteins 0.000 claims description 21
102000037865 fusion proteins Human genes 0.000 claims description 21
238000012217 deletion Methods 0.000 claims description 19
230000037430 deletion Effects 0.000 claims description 19
210000002472 endoplasmic reticulum Anatomy 0.000 claims description 19
239000000203 mixture Substances 0.000 claims description 19
101100184479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN4 gene Proteins 0.000 claims description 18
101001051674 Homo sapiens Meiosis-specific nuclear structural protein 1 Proteins 0.000 claims description 17
102100024962 Meiosis-specific nuclear structural protein 1 Human genes 0.000 claims description 17
108010000165 exo-1,3-alpha-glucanase Proteins 0.000 claims description 16
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 16
239000000126 substance Substances 0.000 claims description 15
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 14
239000013592 cell lysate Substances 0.000 claims description 14
230000002950 deficient Effects 0.000 claims description 14
238000004519 manufacturing process Methods 0.000 claims description 14
102100039371 ER lumen protein-retaining receptor 1 Human genes 0.000 claims description 13
101000812437 Homo sapiens ER lumen protein-retaining receptor 1 Proteins 0.000 claims description 13
101150075484 MNN9 gene Proteins 0.000 claims description 13
101100181264 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR6 gene Proteins 0.000 claims description 12
108010055059 beta-Mannosidase Proteins 0.000 claims description 12
230000000295 complement effect Effects 0.000 claims description 12
102000003839 Human Proteins Human genes 0.000 claims description 11
108090000144 Human Proteins Proteins 0.000 claims description 11
108091000080 Phosphotransferase Proteins 0.000 claims description 11
239000000427 antigen Substances 0.000 claims description 11
108091007433 antigens Proteins 0.000 claims description 11
102000036639 antigens Human genes 0.000 claims description 11
230000027455 binding Effects 0.000 claims description 11
230000002255 enzymatic effect Effects 0.000 claims description 11
102000020233 phosphotransferase Human genes 0.000 claims description 11
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 10
101000739046 Homo sapiens RNA-binding protein PNO1 Proteins 0.000 claims description 10
DINOPBPYOCMGGD-VEDJBHDQSA-N Man(a1-2)Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-3)[Man(a1-2)Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 DINOPBPYOCMGGD-VEDJBHDQSA-N 0.000 claims description 10
102100037294 RNA-binding protein PNO1 Human genes 0.000 claims description 10
238000001727 in vivo Methods 0.000 claims description 10
241001523626 Arxula Species 0.000 claims description 9
241000206602 Eukaryota Species 0.000 claims description 9
102000004366 Glucosidases Human genes 0.000 claims description 9
108010056771 Glucosidases Proteins 0.000 claims description 9
108010017544 Glucosylceramidase Proteins 0.000 claims description 9
102000004547 Glucosylceramidase Human genes 0.000 claims description 9
108010005774 beta-Galactosidase Proteins 0.000 claims description 9
102000005936 beta-Galactosidase Human genes 0.000 claims description 9
239000003102 growth factor Substances 0.000 claims description 9
229920000642 polymer Polymers 0.000 claims description 9
102100022146 Arylsulfatase A Human genes 0.000 claims description 8
108010023546 Aspartylglucosylaminase Proteins 0.000 claims description 8
108090000625 Cathepsin K Proteins 0.000 claims description 8
102000004171 Cathepsin K Human genes 0.000 claims description 8
108010036867 Cerebroside-Sulfatase Proteins 0.000 claims description 8
108010012236 Chemokines Proteins 0.000 claims description 8
102000019034 Chemokines Human genes 0.000 claims description 8
102000004127 Cytokines Human genes 0.000 claims description 8
108090000695 Cytokines Proteins 0.000 claims description 8
108010003272 Hyaluronate lyase Proteins 0.000 claims description 8
102000009066 Hyaluronoglucosaminidase Human genes 0.000 claims description 8
101710096421 Iduronate 2-sulfatase Proteins 0.000 claims description 8
102100029199 Iduronate 2-sulfatase Human genes 0.000 claims description 8
108010003381 Iduronidase Proteins 0.000 claims description 8
102000004627 Iduronidase Human genes 0.000 claims description 8
102000004882 Lipase Human genes 0.000 claims description 8
108090001060 Lipase Proteins 0.000 claims description 8
108010013563 Lipoprotein Lipase Proteins 0.000 claims description 8
102100022119 Lipoprotein lipase Human genes 0.000 claims description 8
102100021003 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase Human genes 0.000 claims description 8
108010027520 N-Acetylgalactosamine-4-Sulfatase Proteins 0.000 claims description 8
101000652829 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) Exo-alpha-sialidase Proteins 0.000 claims description 8
102000011971 Sphingomyelin Phosphodiesterase Human genes 0.000 claims description 8
108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 claims description 8
108010061314 alpha-L-Fucosidase Proteins 0.000 claims description 8
102000012086 alpha-L-Fucosidase Human genes 0.000 claims description 8
102000006995 beta-Glucosidase Human genes 0.000 claims description 8
108010047754 beta-Glucosidase Proteins 0.000 claims description 8
108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 claims description 8
102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 claims description 8
229960002773 hyaluronidase Drugs 0.000 claims description 8
241000233866 Fungi Species 0.000 claims description 7
210000004748 cultured cell Anatomy 0.000 claims description 7
238000000338 in vitro Methods 0.000 claims description 7
108010045758 lysosomal proteins Proteins 0.000 claims description 7
244000052769 pathogen Species 0.000 claims description 7
230000001717 pathogenic effect Effects 0.000 claims description 7
108020005296 Acid Ceramidase Proteins 0.000 claims description 6
102000006772 Acid Ceramidase Human genes 0.000 claims description 6
208000024720 Fabry Disease Diseases 0.000 claims description 6
108010055629 Glucosyltransferases Proteins 0.000 claims description 6
102000000340 Glucosyltransferases Human genes 0.000 claims description 6
108700023372 Glycosyltransferases Proteins 0.000 claims description 6
102000005488 Thioesterase Human genes 0.000 claims description 6
108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 claims description 6
238000012258 culturing Methods 0.000 claims description 6
230000014759 maintenance of location Effects 0.000 claims description 6
108020002982 thioesterase Proteins 0.000 claims description 6
241000228212 Aspergillus Species 0.000 claims description 5
208000015872 Gaucher disease Diseases 0.000 claims description 5
206010053185 Glycogen storage disease type II Diseases 0.000 claims description 5
102000051366 Glycosyltransferases Human genes 0.000 claims description 5
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims description 5
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims description 5
230000004927 fusion Effects 0.000 claims description 5
239000001963 growth medium Substances 0.000 claims description 5
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 claims description 4
102100032487 Beta-mannosidase Human genes 0.000 claims description 4
102100028496 Galactocerebrosidase Human genes 0.000 claims description 4
108010042681 Galactosylceramidase Proteins 0.000 claims description 4
208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 claims description 4
102100033448 Lysosomal alpha-glucosidase Human genes 0.000 claims description 4
208000014060 Niemann-Pick disease Diseases 0.000 claims description 4
208000022292 Tay-Sachs disease Diseases 0.000 claims description 4
108010030291 alpha-Galactosidase Proteins 0.000 claims description 4
102000005840 alpha-Galactosidase Human genes 0.000 claims description 4
201000004502 glycogen storage disease II Diseases 0.000 claims description 4
101100068867 Caenorhabditis elegans glc-1 gene Proteins 0.000 claims description 2
102100031491 Arylsulfatase B Human genes 0.000 claims 2
102000002014 alpha-N-Acetylgalactosaminidase Human genes 0.000 claims 2
241000255925 Diptera Species 0.000 claims 1
101710088235 Envelope glycoprotein C homolog Proteins 0.000 claims 1
101100400378 Mus musculus Marveld2 gene Proteins 0.000 claims 1
235000018102 proteins Nutrition 0.000 description 269
238000004458 analytical method Methods 0.000 description 71
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 60
230000002018 overexpression Effects 0.000 description 52
238000001962 electrophoresis Methods 0.000 description 46
108020004414 DNA Proteins 0.000 description 45
240000004808 Saccharomyces cerevisiae Species 0.000 description 40
101000664600 Homo sapiens Tripartite motif-containing protein 3 Proteins 0.000 description 39
102100038798 Tripartite motif-containing protein 3 Human genes 0.000 description 39
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 37
150000001413 amino acids Chemical class 0.000 description 30
239000000499 gel Substances 0.000 description 29
239000002299 complementary DNA Substances 0.000 description 28
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
241000894007 species Species 0.000 description 27
206010028980 Neoplasm Diseases 0.000 description 26
239000003550 marker Substances 0.000 description 26
235000001014 amino acid Nutrition 0.000 description 25
229940024606 amino acid Drugs 0.000 description 24
101150039297 Alg3 gene Proteins 0.000 description 23
241000235058 Komagataella pastoris Species 0.000 description 23
210000005253 yeast cell Anatomy 0.000 description 23
201000011510 cancer Diseases 0.000 description 22
108020004999 messenger RNA Proteins 0.000 description 22
239000013612 plasmid Substances 0.000 description 22
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
101150050575 URA3 gene Proteins 0.000 description 21
150000002031 dolichols Chemical class 0.000 description 20
239000008194 pharmaceutical composition Substances 0.000 description 20
239000000047 product Substances 0.000 description 20
208000024891 symptom Diseases 0.000 description 20
102000004190 Enzymes Human genes 0.000 description 19
108090000790 Enzymes Proteins 0.000 description 19
229940088598 enzyme Drugs 0.000 description 19
230000010354 integration Effects 0.000 description 19
101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 17
241000196324 Embryophyta Species 0.000 description 16
102100021771 Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase Human genes 0.000 description 16
102100024023 Histone PARylation factor 1 Human genes 0.000 description 16
230000002051 biphasic effect Effects 0.000 description 16
230000002538 fungal effect Effects 0.000 description 16
108091026890 Coding region Proteins 0.000 description 15
230000006698 induction Effects 0.000 description 15
108010009689 mannosyl-oligosaccharide 1,2-alpha-mannosidase Proteins 0.000 description 15
239000002609 medium Substances 0.000 description 15
150000002482 oligosaccharides Chemical class 0.000 description 15
230000004906 unfolded protein response Effects 0.000 description 15
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
108010055817 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Proteins 0.000 description 14
102000000447 Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase Human genes 0.000 description 14
229920001542 oligosaccharide Polymers 0.000 description 14
239000000523 sample Substances 0.000 description 14
210000004102 animal cell Anatomy 0.000 description 13
150000004676 glycans Chemical group 0.000 description 13
230000001939 inductive effect Effects 0.000 description 13
208000027866 inflammatory disease Diseases 0.000 description 13
230000006371 metabolic abnormality Effects 0.000 description 13
101001047783 Homo sapiens Histone PARylation factor 1 Proteins 0.000 description 12
238000002360 preparation method Methods 0.000 description 12
208000011580 syndromic disease Diseases 0.000 description 12
230000001225 therapeutic effect Effects 0.000 description 12
108020004705 Codon Proteins 0.000 description 11
241000124008 Mammalia Species 0.000 description 11
108010076504 Protein Sorting Signals Proteins 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
241000223105 Trypanosoma brucei Species 0.000 description 11
238000007792 addition Methods 0.000 description 11
238000010367 cloning Methods 0.000 description 11
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 11
239000008103 glucose Substances 0.000 description 11
230000001105 regulatory effect Effects 0.000 description 11
238000006467 substitution reaction Methods 0.000 description 11
102100034349 Integrase Human genes 0.000 description 10
101001033265 Mus musculus Interleukin-10 Proteins 0.000 description 10
108700026244 Open Reading Frames Proteins 0.000 description 10
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 10
239000000872 buffer Substances 0.000 description 10
238000010353 genetic engineering Methods 0.000 description 10
239000012528 membrane Substances 0.000 description 10
230000035772 mutation Effects 0.000 description 10
230000002829 reductive effect Effects 0.000 description 10
101150108662 KAR2 gene Proteins 0.000 description 9
230000029087 digestion Effects 0.000 description 9
230000001965 increasing effect Effects 0.000 description 9
210000004379 membrane Anatomy 0.000 description 9
238000002560 therapeutic procedure Methods 0.000 description 9
101150049031 HAC1 gene Proteins 0.000 description 8
101710084378 Lipase 2 Proteins 0.000 description 8
206010027476 Metastases Diseases 0.000 description 8
238000010586 diagram Methods 0.000 description 8
230000009401 metastasis Effects 0.000 description 8
238000003753 real-time PCR Methods 0.000 description 8
241000228245 Aspergillus niger Species 0.000 description 7
241000283690 Bos taurus Species 0.000 description 7
241000282472 Canis lupus familiaris Species 0.000 description 7
241000283707 Capra Species 0.000 description 7
241000282693 Cercopithecidae Species 0.000 description 7
241000282326 Felis catus Species 0.000 description 7
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
241000238631 Hexapoda Species 0.000 description 7
241000700159 Rattus Species 0.000 description 7
101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 7
101150001810 TEAD1 gene Proteins 0.000 description 7
101150074253 TEF1 gene Proteins 0.000 description 7
102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 7
241000235013 Yarrowia Species 0.000 description 7
238000006243 chemical reaction Methods 0.000 description 7
239000003795 chemical substances by application Substances 0.000 description 7
238000012239 gene modification Methods 0.000 description 7
230000005017 genetic modification Effects 0.000 description 7
235000013617 genetically modified food Nutrition 0.000 description 7
230000006801 homologous recombination Effects 0.000 description 7
238000002744 homologous recombination Methods 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
150000002632 lipids Chemical class 0.000 description 7
239000007788 liquid Substances 0.000 description 7
238000003860 storage Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
INOZZBHURUDQQR-AJNGGQMLSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 INOZZBHURUDQQR-AJNGGQMLSA-N 0.000 description 6
239000004475 Arginine Substances 0.000 description 6
241000283153 Cetacea Species 0.000 description 6
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
241000699800 Cricetinae Species 0.000 description 6
101710121417 Envelope glycoprotein Proteins 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 6
241000699694 Gerbillinae Species 0.000 description 6
101001072765 Homo sapiens Neutral alpha-glucosidase AB Proteins 0.000 description 6
102000018942 N-acetylgalactosamine-4-sulfatase activity proteins Human genes 0.000 description 6
102100036592 Neutral alpha-glucosidase AB Human genes 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 6
208000002193 Pain Diseases 0.000 description 6
241000499912 Trichoderma reesei Species 0.000 description 6
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
229910052799 carbon Inorganic materials 0.000 description 6
238000004113 cell culture Methods 0.000 description 6
150000001875 compounds Chemical class 0.000 description 6
108010041601 histidyl-aspartyl-glutamyl-leucine Proteins 0.000 description 6
239000000463 material Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
230000002588 toxic effect Effects 0.000 description 6
230000009466 transformation Effects 0.000 description 6
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
102000005744 Glycoside Hydrolases Human genes 0.000 description 5
108010031186 Glycoside Hydrolases Proteins 0.000 description 5
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
241001465754 Metazoa Species 0.000 description 5
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 5
241000244206 Nematoda Species 0.000 description 5
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 5
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 5
239000002253 acid Substances 0.000 description 5
230000001580 bacterial effect Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000001514 detection method Methods 0.000 description 5
239000003623 enhancer Substances 0.000 description 5
235000011187 glycerol Nutrition 0.000 description 5
230000012010 growth Effects 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
210000004962 mammalian cell Anatomy 0.000 description 5
230000009467 reduction Effects 0.000 description 5
238000006722 reduction reaction Methods 0.000 description 5
230000000717 retained effect Effects 0.000 description 5
238000002864 sequence alignment Methods 0.000 description 5
238000012163 sequencing technique Methods 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000000758 substrate Substances 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
231100000331 toxic Toxicity 0.000 description 5
229940035893 uracil Drugs 0.000 description 5
102100031317 Alpha-N-acetylgalactosaminidase Human genes 0.000 description 4
206010011224 Cough Diseases 0.000 description 4
241000701022 Cytomegalovirus Species 0.000 description 4
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
241000283086 Equidae Species 0.000 description 4
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
206010020751 Hypersensitivity Diseases 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
108091034117 Oligonucleotide Proteins 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
108020005067 RNA Splice Sites Proteins 0.000 description 4
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
238000002105 Southern blotting Methods 0.000 description 4
241000282887 Suidae Species 0.000 description 4
108091023040 Transcription factor Proteins 0.000 description 4
241000223104 Trypanosoma Species 0.000 description 4
241000700605 Viruses Species 0.000 description 4
230000037396 body weight Effects 0.000 description 4
229940041514 candida albicans extract Drugs 0.000 description 4
239000000969 carrier Substances 0.000 description 4
230000008859 change Effects 0.000 description 4
238000004587 chromatography analysis Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
230000006378 damage Effects 0.000 description 4
208000035475 disorder Diseases 0.000 description 4
238000004520 electroporation Methods 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000009472 formulation Methods 0.000 description 4
230000002068 genetic effect Effects 0.000 description 4
102000035122 glycosylated proteins Human genes 0.000 description 4
108091005608 glycosylated proteins Proteins 0.000 description 4
210000002288 golgi apparatus Anatomy 0.000 description 4
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
238000004128 high performance liquid chromatography Methods 0.000 description 4
239000000411 inducer Substances 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
238000002955 isolation Methods 0.000 description 4
108010005335 mannoproteins Proteins 0.000 description 4
239000002245 particle Substances 0.000 description 4
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
230000008569 process Effects 0.000 description 4
230000004044 response Effects 0.000 description 4
230000002441 reversible effect Effects 0.000 description 4
235000004400 serine Nutrition 0.000 description 4
239000004055 small Interfering RNA Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
239000012138 yeast extract Substances 0.000 description 4
101150092249 ALG6 gene Proteins 0.000 description 3
102100036826 Aldehyde oxidase Human genes 0.000 description 3
241000271566 Aves Species 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
206010010904 Convulsion Diseases 0.000 description 3
241000938605 Crocodylia Species 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
206010058314 Dysplasia Diseases 0.000 description 3
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
241000283073 Equus caballus Species 0.000 description 3
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 3
239000004471 Glycine Substances 0.000 description 3
108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
101710154606 Hemagglutinin Proteins 0.000 description 3
241000282412 Homo Species 0.000 description 3
101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 3
241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
241001506991 Komagataella phaffii GS115 Species 0.000 description 3
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
241000270322 Lepidosauria Species 0.000 description 3
206010052904 Musculoskeletal stiffness Diseases 0.000 description 3
108091006036 N-glycosylated proteins Proteins 0.000 description 3
108010025020 Nerve Growth Factor Proteins 0.000 description 3
101710093908 Outer capsid protein VP4 Proteins 0.000 description 3
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 3
239000001888 Peptone Substances 0.000 description 3
108010080698 Peptones Proteins 0.000 description 3
108010002747 Pfu DNA polymerase Proteins 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
241000235648 Pichia Species 0.000 description 3
101710176177 Protein A56 Proteins 0.000 description 3
206010037660 Pyrexia Diseases 0.000 description 3
208000021386 Sjogren Syndrome Diseases 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
102000040945 Transcription factor Human genes 0.000 description 3
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
108020002494 acetyltransferase Proteins 0.000 description 3
102000005421 acetyltransferase Human genes 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000007815 allergy Effects 0.000 description 3
108010039255 alpha 1,6-mannosyltransferase Proteins 0.000 description 3
238000003556 assay Methods 0.000 description 3
230000008901 benefit Effects 0.000 description 3
DKXNBNKWCZZMJT-VOXHDCLVSA-N beta-D-glucosyl-(1->4)-aldehydo-D-mannose Chemical compound O=C[C@@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DKXNBNKWCZZMJT-VOXHDCLVSA-N 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
230000030833 cell death Effects 0.000 description 3
230000006037 cell lysis Effects 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000007812 deficiency Effects 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
238000005194 fractionation Methods 0.000 description 3
239000000185 hemagglutinin Substances 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000003119 immunoblot Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000002452 interceptive effect Effects 0.000 description 3
239000000543 intermediate Substances 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
239000006166 lysate Substances 0.000 description 3
230000000051 modifying effect Effects 0.000 description 3
201000006417 multiple sclerosis Diseases 0.000 description 3
201000006938 muscular dystrophy Diseases 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
210000003463 organelle Anatomy 0.000 description 3
235000019319 peptone Nutrition 0.000 description 3
229920002401 polyacrylamide Polymers 0.000 description 3
238000003752 polymerase chain reaction Methods 0.000 description 3
229910000160 potassium phosphate Inorganic materials 0.000 description 3
235000011009 potassium phosphates Nutrition 0.000 description 3
230000000750 progressive effect Effects 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
238000000746 purification Methods 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000005215 recombination Methods 0.000 description 3
230000003362 replicative effect Effects 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
230000028327 secretion Effects 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
230000008685 targeting Effects 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
239000006163 transport media Substances 0.000 description 3
238000009966 trimming Methods 0.000 description 3
239000004474 valine Substances 0.000 description 3
239000007222 ypd medium Substances 0.000 description 3
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
206010000060 Abdominal distension Diseases 0.000 description 2
HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
241000351920 Aspergillus nidulans Species 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
102100023702 C-C motif chemokine 13 Human genes 0.000 description 2
102100023700 C-C motif chemokine 16 Human genes 0.000 description 2
102100032366 C-C motif chemokine 7 Human genes 0.000 description 2
101100130886 Candida albicans (strain SC5314 / ATCC MYA-2876) MNT1 gene Proteins 0.000 description 2
102000004201 Ceramidases Human genes 0.000 description 2
108090000751 Ceramidases Proteins 0.000 description 2
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
108010051219 Cre recombinase Proteins 0.000 description 2
208000014311 Cushing syndrome Diseases 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
108700039887 Essential Genes Proteins 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
QGWNDRXFNXRZMB-UUOKFMHZSA-N GDP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O QGWNDRXFNXRZMB-UUOKFMHZSA-N 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
108010070675 Glutathione transferase Proteins 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
102000004858 Growth differentiation factor-9 Human genes 0.000 description 2
108090001086 Growth differentiation factor-9 Proteins 0.000 description 2
102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
101150009006 HIS3 gene Proteins 0.000 description 2
101150069554 HIS4 gene Proteins 0.000 description 2
102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 2
101000801742 Homo sapiens Triosephosphate isomerase Proteins 0.000 description 2
101001033034 Homo sapiens UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase Proteins 0.000 description 2
241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
241000701806 Human papillomavirus Species 0.000 description 2
108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
108010002352 Interleukin-1 Proteins 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
101150053531 MNN1 gene Proteins 0.000 description 2
101150030705 MNS1 gene Proteins 0.000 description 2
102100025315 Mannosyl-oligosaccharide glucosidase Human genes 0.000 description 2
108700011259 MicroRNAs Proteins 0.000 description 2
101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 2
208000008955 Mucolipidoses Diseases 0.000 description 2
206010028095 Mucopolysaccharidosis IV Diseases 0.000 description 2
101000946797 Mus musculus C-C motif chemokine 9 Proteins 0.000 description 2
101100192157 Mus musculus Psen2 gene Proteins 0.000 description 2
108010056852 Myostatin Proteins 0.000 description 2
206010028813 Nausea Diseases 0.000 description 2
102000015336 Nerve Growth Factor Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
102100038358 Prostate-specific antigen Human genes 0.000 description 2
239000004365 Protease Substances 0.000 description 2
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 2
241000714474 Rous sarcoma virus Species 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
108091027967 Small hairpin RNA Proteins 0.000 description 2
108020004459 Small interfering RNA Proteins 0.000 description 2
102000013275 Somatomedins Human genes 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
206010057040 Temperature intolerance Diseases 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
102000036693 Thrombopoietin Human genes 0.000 description 2
108010041111 Thrombopoietin Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102000004357 Transferases Human genes 0.000 description 2
108090000992 Transferases Proteins 0.000 description 2
241000223260 Trichoderma harzianum Species 0.000 description 2
102100033598 Triosephosphate isomerase Human genes 0.000 description 2
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
102100038413 UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase Human genes 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
XCCTYIAWTASOJW-XVFCMESISA-N Uridine-5'-Diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-XVFCMESISA-N 0.000 description 2
208000024780 Urticaria Diseases 0.000 description 2
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
102100039037 Vascular endothelial growth factor A Human genes 0.000 description 2
240000001417 Vigna umbellata Species 0.000 description 2
235000011453 Vigna umbellata Nutrition 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
239000012190 activator Substances 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
230000002411 adverse Effects 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000003321 amplification Effects 0.000 description 2
208000007502 anemia Diseases 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
239000003435 antirheumatic agent Substances 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
239000011324 bead Substances 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
229960000074 biopharmaceutical Drugs 0.000 description 2
229940112869 bone morphogenetic protein Drugs 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
230000000711 cancerogenic effect Effects 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
239000002775 capsule Substances 0.000 description 2
231100000315 carcinogenic Toxicity 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
239000006143 cell culture medium Substances 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
239000013599 cloning vector Substances 0.000 description 2
238000002648 combination therapy Methods 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
238000007405 data analysis Methods 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
239000002988 disease modifying antirheumatic drug Substances 0.000 description 2
208000002173 dizziness Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
230000004064 dysfunction Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
231100000655 enterotoxin Toxicity 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
231100000776 exotoxin Toxicity 0.000 description 2
239000002095 exotoxin Substances 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
239000012530 fluid Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
108010050669 glucosidase I Proteins 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
235000004554 glutamine Nutrition 0.000 description 2
239000005090 green fluorescent protein Substances 0.000 description 2
QGWNDRXFNXRZMB-UHFFFAOYSA-N guanidine diphosphate Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O QGWNDRXFNXRZMB-UHFFFAOYSA-N 0.000 description 2
RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
235000013928 guanylic acid Nutrition 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
239000000367 immunologic factor Substances 0.000 description 2
230000002637 immunotoxin Effects 0.000 description 2
239000002596 immunotoxin Substances 0.000 description 2
231100000608 immunotoxin Toxicity 0.000 description 2
229940051026 immunotoxin Drugs 0.000 description 2
239000007943 implant Substances 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
208000016245 inborn errors of metabolism Diseases 0.000 description 2
210000004969 inflammatory cell Anatomy 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
208000015978 inherited metabolic disease Diseases 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
238000001361 intraarterial administration Methods 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 2
238000004255 ion exchange chromatography Methods 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
238000002372 labelling Methods 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
230000004576 lipid-binding Effects 0.000 description 2
239000002502 liposome Substances 0.000 description 2
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
230000004060 metabolic process Effects 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
239000002679 microRNA Substances 0.000 description 2
238000001823 molecular biology technique Methods 0.000 description 2
208000005264 motor neuron disease Diseases 0.000 description 2
208000010978 mucopolysaccharidosis type 4 Diseases 0.000 description 2
229950006780 n-acetylglucosamine Drugs 0.000 description 2
230000008693 nausea Effects 0.000 description 2
239000013642 negative control Substances 0.000 description 2
229940053128 nerve growth factor Drugs 0.000 description 2
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
239000002674 ointment Substances 0.000 description 2
201000008152 organic acidemia Diseases 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
201000009395 primary hyperaldosteronism Diseases 0.000 description 2
230000004952 protein activity Effects 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
238000006268 reductive amination reaction Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
230000003938 response to stress Effects 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
231100000617 superantigen Toxicity 0.000 description 2
239000013589 supplement Substances 0.000 description 2
238000013268 sustained release Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
230000009747 swallowing Effects 0.000 description 2
230000035900 sweating Effects 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
201000000596 systemic lupus erythematosus Diseases 0.000 description 2
239000003826 tablet Substances 0.000 description 2
235000008521 threonine Nutrition 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000011200 topical administration Methods 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000011269 treatment regimen Methods 0.000 description 2
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
235000002374 tyrosine Nutrition 0.000 description 2
DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 2
230000008673 vomiting Effects 0.000 description 2
238000001262 western blot Methods 0.000 description 2
101150084750 1 gene Proteins 0.000 description 1
DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 1
ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
101150103244 ACT1 gene Proteins 0.000 description 1
208000026466 ALG3-CDG Diseases 0.000 description 1
208000037190 ALG6-CDG Diseases 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
201000007994 Aceruloplasminemia Diseases 0.000 description 1
206010000599 Acromegaly Diseases 0.000 description 1
208000026872 Addison Disease Diseases 0.000 description 1
201000011452 Adrenoleukodystrophy Diseases 0.000 description 1
102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 1
101710193111 All-trans-retinol dehydrogenase [NAD(+)] ADH4 Proteins 0.000 description 1
208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
102100026611 Alpha-1,2-mannosyltransferase ALG9 Human genes 0.000 description 1
102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
208000029602 Alpha-N-acetylgalactosaminidase deficiency Diseases 0.000 description 1
208000031277 Amaurotic familial idiocy Diseases 0.000 description 1
206010001935 American trypanosomiasis Diseases 0.000 description 1
208000029751 Amino acid metabolism disease Diseases 0.000 description 1
108091093088 Amplicon Proteins 0.000 description 1
208000028185 Angioedema Diseases 0.000 description 1
108010087765 Antipain Proteins 0.000 description 1
208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
108010039627 Aprotinin Proteins 0.000 description 1
208000006820 Arthralgia Diseases 0.000 description 1
206010003402 Arthropod sting Diseases 0.000 description 1
241001465318 Aspergillus terreus Species 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
108010078286 Ataxins Proteins 0.000 description 1
102000014461 Ataxins Human genes 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 description 1
208000026340 B4GALT1-CDG Diseases 0.000 description 1
108700020463 BRCA1 Proteins 0.000 description 1
102000036365 BRCA1 Human genes 0.000 description 1
101150072950 BRCA1 gene Proteins 0.000 description 1
101000959414 Bacillus thermoamyloliquefaciens Alpha-glucosidase 2 Proteins 0.000 description 1
208000008035 Back Pain Diseases 0.000 description 1
108010023063 Bacto-peptone Proteins 0.000 description 1
208000009137 Behcet syndrome Diseases 0.000 description 1
FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
108010006654 Bleomycin Proteins 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
206010005949 Bone cancer Diseases 0.000 description 1
208000018084 Bone neoplasm Diseases 0.000 description 1
241000512364 Botryosphaeria agaves Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
206010006272 Breast mass Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
206010059027 Brugada syndrome Diseases 0.000 description 1
102100036841 C-C motif chemokine 1 Human genes 0.000 description 1
101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
102100023705 C-C motif chemokine 14 Human genes 0.000 description 1
102100023703 C-C motif chemokine 15 Human genes 0.000 description 1
102100023698 C-C motif chemokine 17 Human genes 0.000 description 1
102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
102100036849 C-C motif chemokine 24 Human genes 0.000 description 1
102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
101710155834 C-C motif chemokine 7 Proteins 0.000 description 1
102100034871 C-C motif chemokine 8 Human genes 0.000 description 1
101710155833 C-C motif chemokine 8 Proteins 0.000 description 1
108700012434 CCL3 Proteins 0.000 description 1
WSNMPAVSZJSIMT-UHFFFAOYSA-N COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 Chemical compound COc1c(C)c2COC(=O)c2c(O)c1CC(O)C1(C)CCC(=O)O1 WSNMPAVSZJSIMT-UHFFFAOYSA-N 0.000 description 1
101100068866 Caenorhabditis elegans glc-2 gene Proteins 0.000 description 1
KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
101100184477 Candida albicans (strain SC5314 / ATCC MYA-2876) MNN2 gene Proteins 0.000 description 1
101100184475 Candida albicans (strain SC5314 / ATCC MYA-2876) MNN24 gene Proteins 0.000 description 1
241000222178 Candida tropicalis Species 0.000 description 1
208000031229 Cardiomyopathies Diseases 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
208000002177 Cataract Diseases 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
206010008025 Cerebellar ataxia Diseases 0.000 description 1
206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 1
206010008342 Cervix carcinoma Diseases 0.000 description 1
108010083647 Chemokine CCL24 Proteins 0.000 description 1
102000000013 Chemokine CCL3 Human genes 0.000 description 1
108010055165 Chemokine CCL4 Proteins 0.000 description 1
102000001326 Chemokine CCL4 Human genes 0.000 description 1
108010055166 Chemokine CCL5 Proteins 0.000 description 1
206010008479 Chest Pain Diseases 0.000 description 1
102100040428 Chitobiosyldiphosphodolichol beta-mannosyltransferase Human genes 0.000 description 1
102000003914 Cholinesterases Human genes 0.000 description 1
108090000322 Cholinesterases Proteins 0.000 description 1
208000005595 Chronic Idiopathic Jaundice Diseases 0.000 description 1
208000006344 Churg-Strauss Syndrome Diseases 0.000 description 1
208000029448 Chylomicron retention disease Diseases 0.000 description 1
108010004103 Chylomicrons Proteins 0.000 description 1
208000025678 Ciliary Motility disease Diseases 0.000 description 1
208000003449 Classical Lissencephalies and Subcortical Band Heterotopias Diseases 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
206010010099 Combined immunodeficiency Diseases 0.000 description 1
208000000454 Congenital Hyperinsulinism Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
208000026372 Congenital cystic kidney disease Diseases 0.000 description 1
206010010510 Congenital hypothyroidism Diseases 0.000 description 1
206010010582 Congenital osteodystrophy Diseases 0.000 description 1
208000016998 Conn syndrome Diseases 0.000 description 1
206010010774 Constipation Diseases 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
241000222716 Crithidia Species 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
208000026292 Cystic Kidney disease Diseases 0.000 description 1
206010011777 Cystinosis Diseases 0.000 description 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
208000037181 DPM1-CDG Diseases 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
208000011518 Danon disease Diseases 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
206010048768 Dermatosis Diseases 0.000 description 1
241001480031 Dipodascaceae Species 0.000 description 1
241001123635 Dipodascus Species 0.000 description 1
241001123634 Dipodascus albidus Species 0.000 description 1
102100040381 Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase Human genes 0.000 description 1
102100032339 Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase Human genes 0.000 description 1
102100020746 Dolichol-phosphate mannosyltransferase subunit 1 Human genes 0.000 description 1
102100034583 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 Human genes 0.000 description 1
102100039216 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 2 Human genes 0.000 description 1
102100039486 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 4 Human genes 0.000 description 1
102100039104 Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Human genes 0.000 description 1
108010089072 Dolichyl-diphosphooligosaccharide-protein glycotransferase Proteins 0.000 description 1
102100027189 Dolichyl-phosphate beta-glucosyltransferase Human genes 0.000 description 1
206010013700 Drug hypersensitivity Diseases 0.000 description 1
201000004943 Dubin-Johnson syndrome Diseases 0.000 description 1
208000007652 Dysostoses Diseases 0.000 description 1
201000001324 Dysostosis Diseases 0.000 description 1
208000000059 Dyspnea Diseases 0.000 description 1
206010013975 Dyspnoeas Diseases 0.000 description 1
206010014561 Emphysema Diseases 0.000 description 1
101710112422 Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase Proteins 0.000 description 1
241000224559 Endotrypanum Species 0.000 description 1
208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 1
102100023688 Eotaxin Human genes 0.000 description 1
101710139422 Eotaxin Proteins 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
108010008165 Etanercept Proteins 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
108010014172 Factor V Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
108700000224 Familial apoceruloplasmin deficiency Proteins 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
201000007888 Finnish type amyloidosis Diseases 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
208000004262 Food Hypersensitivity Diseases 0.000 description 1
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
102100033821 GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase Human genes 0.000 description 1
241001123633 Galactomyces Species 0.000 description 1
208000017462 Galactosialidosis Diseases 0.000 description 1
102100024637 Galectin-10 Human genes 0.000 description 1
101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
208000009796 Gangliosidoses Diseases 0.000 description 1
206010061974 Gastrointestinal obstruction Diseases 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
244000168141 Geotrichum candidum Species 0.000 description 1
208000007465 Giant cell arteritis Diseases 0.000 description 1
208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
102400000321 Glucagon Human genes 0.000 description 1
108060003199 Glucagon Proteins 0.000 description 1
102100021223 Glucosidase 2 subunit beta Human genes 0.000 description 1
108010060309 Glucuronidase Proteins 0.000 description 1
102000053187 Glucuronidase Human genes 0.000 description 1
208000001500 Glycogen Storage Disease Type IIb Diseases 0.000 description 1
208000035148 Glycogen storage disease due to LAMP-2 deficiency Diseases 0.000 description 1
101710162064 Glycoprotein endo-alpha-1,2-mannosidase Proteins 0.000 description 1
102100023177 Glycoprotein endo-alpha-1,2-mannosidase Human genes 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 1
208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
241000985907 Gymnoascus reesii Species 0.000 description 1
108700024827 HOC1 Proteins 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
206010019842 Hepatomegaly Diseases 0.000 description 1
206010019860 Hereditary angioedema Diseases 0.000 description 1
208000028572 Hereditary chronic pancreatitis Diseases 0.000 description 1
208000033981 Hereditary haemochromatosis Diseases 0.000 description 1
206010056976 Hereditary pancreatitis Diseases 0.000 description 1
241000224517 Herpetomonas Species 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
108010093488 His-His-His-His-His-His Proteins 0.000 description 1
101000717828 Homo sapiens Alpha-1,2-mannosyltransferase ALG9 Proteins 0.000 description 1
101000891547 Homo sapiens Alpha-1,3/1,6-mannosyltransferase ALG2 Proteins 0.000 description 1
101000718525 Homo sapiens Alpha-galactosidase A Proteins 0.000 description 1
101000713104 Homo sapiens C-C motif chemokine 1 Proteins 0.000 description 1
101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 1
101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 1
101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 description 1
101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
101000891557 Homo sapiens Chitobiosyldiphosphodolichol beta-mannosyltransferase Proteins 0.000 description 1
101000890957 Homo sapiens Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase Proteins 0.000 description 1
101000797862 Homo sapiens Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase Proteins 0.000 description 1
101000932202 Homo sapiens Dolichol-phosphate mannosyltransferase subunit 1 Proteins 0.000 description 1
101001130785 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48 kDa subunit Proteins 0.000 description 1
101000848781 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 Proteins 0.000 description 1
101000670093 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 2 Proteins 0.000 description 1
101000609775 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 4 Proteins 0.000 description 1
101000884921 Homo sapiens Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit DAD1 Proteins 0.000 description 1
101000694130 Homo sapiens Dolichyl-phosphate beta-glucosyltransferase Proteins 0.000 description 1
101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 1
101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 1
101000779347 Homo sapiens GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase Proteins 0.000 description 1
101001040875 Homo sapiens Glucosidase 2 subunit beta Proteins 0.000 description 1
101000717815 Homo sapiens Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase Proteins 0.000 description 1
101000579716 Homo sapiens Protein RFT1 homolog Proteins 0.000 description 1
101000797874 Homo sapiens Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Proteins 0.000 description 1
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
101000836466 Homo sapiens UDP-N-acetylglucosamine transferase subunit ALG14 homolog Proteins 0.000 description 1
101000649993 Homo sapiens WW domain-binding protein 1 Proteins 0.000 description 1
241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
108700037017 Hyaluronidase Deficiency Proteins 0.000 description 1
208000005503 Hyaluronidase deficiency Diseases 0.000 description 1
208000008454 Hyperhidrosis Diseases 0.000 description 1
208000033892 Hyperhomocysteinemia Diseases 0.000 description 1
208000001021 Hyperlipoproteinemia Type I Diseases 0.000 description 1
208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010020843 Hyperthermia Diseases 0.000 description 1
206010020852 Hypertonia Diseases 0.000 description 1
206010051125 Hypofibrinogenaemia Diseases 0.000 description 1
208000029663 Hypophosphatemia Diseases 0.000 description 1
208000001953 Hypotension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
208000001019 Inborn Errors Metabolism Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108090000174 Interleukin-10 Proteins 0.000 description 1
108010065805 Interleukin-12 Proteins 0.000 description 1
108090000176 Interleukin-13 Proteins 0.000 description 1
108090000172 Interleukin-15 Proteins 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
208000029523 Interstitial Lung disease Diseases 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
206010023232 Joint swelling Diseases 0.000 description 1
206010023379 Ketoacidosis Diseases 0.000 description 1
208000007976 Ketosis Diseases 0.000 description 1
208000008839 Kidney Neoplasms Diseases 0.000 description 1
101100488151 Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) YEA4 gene Proteins 0.000 description 1
208000028226 Krabbe disease Diseases 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
101150021155 LIP2 gene Proteins 0.000 description 1
206010023804 Large intestine perforation Diseases 0.000 description 1
208000006302 Laron syndrome Diseases 0.000 description 1
241000222722 Leishmania <genus> Species 0.000 description 1
241000222698 Leptomonas Species 0.000 description 1
208000030514 Leukocyte adhesion deficiency type II Diseases 0.000 description 1
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
201000009342 Limb-girdle muscular dystrophy Diseases 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
206010067125 Liver injury Diseases 0.000 description 1
208000007623 Lordosis Diseases 0.000 description 1
208000008930 Low Back Pain Diseases 0.000 description 1
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
206010024971 Lower respiratory tract infections Diseases 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000016896 MGAT2-CDG Diseases 0.000 description 1
101150093457 MNN2 gene Proteins 0.000 description 1
101150102717 MNN4 gene Proteins 0.000 description 1
101150042047 MNN5 gene Proteins 0.000 description 1
208000010829 MOGS-CDG Diseases 0.000 description 1
208000031008 MPDU1-CDG Diseases 0.000 description 1
208000012213 MPI-CDG Diseases 0.000 description 1
208000035719 Maculopathy Diseases 0.000 description 1
241000178260 Magnusiomyces ingens Species 0.000 description 1
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000036626 Mental retardation Diseases 0.000 description 1
206010027452 Metastases to bone Diseases 0.000 description 1
206010027457 Metastases to liver Diseases 0.000 description 1
206010027458 Metastases to lung Diseases 0.000 description 1
208000023277 Microvillous inclusion disease Diseases 0.000 description 1
208000026940 Microvillus inclusion disease Diseases 0.000 description 1
206010049567 Miller Fisher syndrome Diseases 0.000 description 1
201000004246 Miller-Dieker lissencephaly syndrome Diseases 0.000 description 1
208000035022 Miller-Dieker syndrome Diseases 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
208000003430 Mitral Valve Prolapse Diseases 0.000 description 1
208000034819 Mobility Limitation Diseases 0.000 description 1
208000000475 Mohr-Tranebjaerg syndrome Diseases 0.000 description 1
102000005431 Molecular Chaperones Human genes 0.000 description 1
108010006519 Molecular Chaperones Proteins 0.000 description 1
208000026072 Motor neurone disease Diseases 0.000 description 1
102000015728 Mucins Human genes 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
206010072928 Mucolipidosis type II Diseases 0.000 description 1
208000003452 Multiple Hereditary Exostoses Diseases 0.000 description 1
208000000149 Multiple Sulfatase Deficiency Disease Diseases 0.000 description 1
208000035032 Multiple sulfatase deficiency Diseases 0.000 description 1
101000713102 Mus musculus C-C motif chemokine 1 Proteins 0.000 description 1
101000978374 Mus musculus C-C motif chemokine 12 Proteins 0.000 description 1
101001034845 Mus musculus Interferon-induced transmembrane protein 3 Proteins 0.000 description 1
208000007101 Muscle Cramp Diseases 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
208000033833 Myelomonocytic Chronic Leukemia Diseases 0.000 description 1
102400000569 Myeloperoxidase Human genes 0.000 description 1
108090000235 Myeloperoxidases Proteins 0.000 description 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
MTKHIHRESQZDQJ-UHFFFAOYSA-N NC1=C(C=CC(C(S(O)(=O)=O)=C2)=C3C(C=C4)=C2S(O)(=O)=O)C3=C4C(S(O)(=O)=O)=C1.P Chemical compound NC1=C(C=CC(C(S(O)(=O)=O)=C2)=C3C(C=C4)=C2S(O)(=O)=O)C3=C4C(S(O)(=O)=O)=C1.P MTKHIHRESQZDQJ-UHFFFAOYSA-N 0.000 description 1
GVQYIMKPSDOTAH-UHFFFAOYSA-N NCC 1 Natural products CC1=C(C=C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(C2C=3NC(CC4=C(C(C)=C(C=O)N4)CCOC(=O)CC(O)=O)=C(C)C=3C(=O)C2C(O)=O)N1 GVQYIMKPSDOTAH-UHFFFAOYSA-N 0.000 description 1
201000005118 Nephrogenic diabetes insipidus Diseases 0.000 description 1
102000007072 Nerve Growth Factors Human genes 0.000 description 1
208000003450 Neurogenic Diabetes Insipidus Diseases 0.000 description 1
206010060860 Neurological symptom Diseases 0.000 description 1
208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
208000002366 Nut Hypersensitivity Diseases 0.000 description 1
101150024689 OST3 gene Proteins 0.000 description 1
208000019851 Opitz G/BBB syndrome Diseases 0.000 description 1
208000033716 Organic aciduria Diseases 0.000 description 1
206010031123 Orthopnoea Diseases 0.000 description 1
206010031243 Osteogenesis imperfecta Diseases 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
208000016899 PMM2-CDG Diseases 0.000 description 1
206010053869 POEMS syndrome Diseases 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
229930012538 Paclitaxel Natural products 0.000 description 1
241000282577 Pan troglodytes Species 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
101000713179 Papio hamadryas Solute carrier family 52, riboflavin transporter, member 2 Proteins 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
208000004843 Pendred Syndrome Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
102000015439 Phospholipases Human genes 0.000 description 1
108010064785 Phospholipases Proteins 0.000 description 1
241000224565 Phytomonas Species 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
HZEBHPIOVYHPMT-OUBTZVSYSA-N Polonium-210 Chemical compound [210Po] HZEBHPIOVYHPMT-OUBTZVSYSA-N 0.000 description 1
206010036030 Polyarthritis Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
208000007048 Polymyalgia Rheumatica Diseases 0.000 description 1
206010036105 Polyneuropathy Diseases 0.000 description 1
208000037062 Polyps Diseases 0.000 description 1
208000016855 Porphyrin metabolism disease Diseases 0.000 description 1
208000004777 Primary Hyperoxaluria Diseases 0.000 description 1
206010036697 Primary hypothyroidism Diseases 0.000 description 1
102100026610 Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase Human genes 0.000 description 1
102100034785 Programmed cell death protein 6 Human genes 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
201000005660 Protein C Deficiency Diseases 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
102100032337 Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Human genes 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
208000012322 Raynaud phenomenon Diseases 0.000 description 1
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
108010091086 Recombinases Proteins 0.000 description 1
102000018120 Recombinases Human genes 0.000 description 1
206010038389 Renal cancer Diseases 0.000 description 1
208000037656 Respiratory Sounds Diseases 0.000 description 1
206010038910 Retinitis Diseases 0.000 description 1
208000007014 Retinitis pigmentosa Diseases 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
101150099625 STT3 gene Proteins 0.000 description 1
101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
101100178273 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HOC1 gene Proteins 0.000 description 1
101100454113 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KRE2 gene Proteins 0.000 description 1
101100181259 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR1 gene Proteins 0.000 description 1
101100181260 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR2 gene Proteins 0.000 description 1
101100181261 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KTR3 gene Proteins 0.000 description 1
101100457678 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN10 gene Proteins 0.000 description 1
101100457679 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNN11 gene Proteins 0.000 description 1
101100130881 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MNS1 gene Proteins 0.000 description 1
101100188881 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OST6 gene Proteins 0.000 description 1
101100545063 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YUR1 gene Proteins 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
201000000552 Scott syndrome Diseases 0.000 description 1
206010039808 Secondary aldosteronism Diseases 0.000 description 1
206010040070 Septic Shock Diseases 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
206010040829 Skin discolouration Diseases 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
102100036863 Solute carrier family 52, riboflavin transporter, member 1 Human genes 0.000 description 1
208000005392 Spasm Diseases 0.000 description 1
206010041591 Spinal osteoarthritis Diseases 0.000 description 1
208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
206010041660 Splenomegaly Diseases 0.000 description 1
208000006045 Spondylarthropathies Diseases 0.000 description 1
208000005718 Stomach Neoplasms Diseases 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
208000001106 Takayasu Arteritis Diseases 0.000 description 1
208000001163 Tangier disease Diseases 0.000 description 1
206010043189 Telangiectasia Diseases 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
208000024770 Thyroid neoplasm Diseases 0.000 description 1
108700013819 Thyroxine-Binding Globulin Deficiency Proteins 0.000 description 1
206010044248 Toxic shock syndrome Diseases 0.000 description 1
231100000650 Toxic shock syndrome Toxicity 0.000 description 1
241000223259 Trichoderma Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241000223109 Trypanosoma cruzi Species 0.000 description 1
208000026911 Tuberous sclerosis complex Diseases 0.000 description 1
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
102100027277 UDP-N-acetylglucosamine transferase subunit ALG14 homolog Human genes 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
208000014769 Usher Syndromes Diseases 0.000 description 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
206010046788 Uterine haemorrhage Diseases 0.000 description 1
101150111043 VAN1 gene Proteins 0.000 description 1
206010046910 Vaginal haemorrhage Diseases 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
208000027276 Von Willebrand disease Diseases 0.000 description 1
102100028279 WW domain-binding protein 1 Human genes 0.000 description 1
206010047924 Wheezing Diseases 0.000 description 1
241000193624 Wickerhamiella Species 0.000 description 1
208000026589 Wolman disease Diseases 0.000 description 1
208000031970 X-linked Charcot-Marie-Tooth disease Diseases 0.000 description 1
208000010796 X-linked adrenoleukodystrophy Diseases 0.000 description 1
101100361162 Yarrowia lipolytica (strain CLIB 122 / E 150) ROT1 gene Proteins 0.000 description 1
108700032257 Yarrowia lipolytica LIP2 Proteins 0.000 description 1
108700024496 Yarrowia lipolytica YLLIP2 Proteins 0.000 description 1
201000004525 Zellweger Syndrome Diseases 0.000 description 1
208000036813 Zellweger spectrum disease Diseases 0.000 description 1
241000782624 Zema Species 0.000 description 1
241000222676 Zygoascus Species 0.000 description 1
GBXZONVFWYCRPT-KVTDHHQDSA-N [(2s,3s,4r,5r)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] dihydrogen phosphate Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](C=O)OP(O)(O)=O GBXZONVFWYCRPT-KVTDHHQDSA-N 0.000 description 1
241001149679 [Candida] apicola Species 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
208000004622 abetalipoproteinemia Diseases 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000003916 acid precipitation Methods 0.000 description 1
238000010306 acid treatment Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
101150102866 adc1 gene Proteins 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
201000009628 adenosine deaminase deficiency Diseases 0.000 description 1
230000001919 adrenal effect Effects 0.000 description 1
229940009456 adriamycin Drugs 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
108010091628 alpha 1-Antichymotrypsin Proteins 0.000 description 1
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
238000000137 annealing Methods 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
208000008784 apnea Diseases 0.000 description 1
230000004596 appetite loss Effects 0.000 description 1
229960004405 aprotinin Drugs 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
201000004562 autosomal dominant cerebellar ataxia Diseases 0.000 description 1
208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 description 1
208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 1
VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229960001561 bleomycin Drugs 0.000 description 1
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
208000024330 bloating Diseases 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000006931 brain damage Effects 0.000 description 1
231100000874 brain damage Toxicity 0.000 description 1
208000029028 brain injury Diseases 0.000 description 1
238000010805 cDNA synthesis kit Methods 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229940127093 camptothecin Drugs 0.000 description 1
VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
229960003669 carbenicillin Drugs 0.000 description 1
208000020450 carbohydrate metabolism disease Diseases 0.000 description 1
229960004562 carboplatin Drugs 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
101150055766 cat gene Proteins 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000010307 cell transformation Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000030570 cellular localization Effects 0.000 description 1
201000010881 cervical cancer Diseases 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
230000009920 chelation Effects 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
229940044683 chemotherapy drug Drugs 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
229960004630 chlorambucil Drugs 0.000 description 1
JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
208000024042 cholesterol ester storage disease Diseases 0.000 description 1
208000013760 cholesteryl ester storage disease Diseases 0.000 description 1
229940048961 cholinesterase Drugs 0.000 description 1
230000002648 chondrogenic effect Effects 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
208000013116 chronic cough Diseases 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
201000010902 chronic myelomonocytic leukemia Diseases 0.000 description 1
208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
235000019504 cigarettes Nutrition 0.000 description 1
230000007882 cirrhosis Effects 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
230000006690 co-activation Effects 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
108700036934 congenital Sucrase-isomaltase deficiency Proteins 0.000 description 1
208000006520 congenital disorder of glycosylation type 1C Diseases 0.000 description 1
208000003871 congenital disorder of glycosylation type 1E Diseases 0.000 description 1
201000001578 congenital disorder of glycosylation type IIa Diseases 0.000 description 1
201000001577 congenital disorder of glycosylation type IIb Diseases 0.000 description 1
201000001575 congenital disorder of glycosylation type IIc Diseases 0.000 description 1
201000001572 congenital disorder of glycosylation type IId Diseases 0.000 description 1
208000001970 congenital sucrase-isomaltase deficiency Diseases 0.000 description 1
208000018631 connective tissue disease Diseases 0.000 description 1
230000036461 convulsion Effects 0.000 description 1
OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000005138 cryopreservation Methods 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
229960004397 cyclophosphamide Drugs 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
229960000975 daunorubicin Drugs 0.000 description 1
201000008696 deafness-dystonia-optic neuronopathy syndrome Diseases 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
230000008021 deposition Effects 0.000 description 1
201000001981 dermatomyositis Diseases 0.000 description 1
238000003795 desorption Methods 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
201000010064 diabetes insipidus Diseases 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
229940079919 digestives enzyme preparation Drugs 0.000 description 1
229960003983 diphtheria toxoid Drugs 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
208000029230 disorder of organic acid metabolism Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
238000011143 downstream manufacturing Methods 0.000 description 1
229960004679 doxorubicin Drugs 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000000635 electron micrograph Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000009585 enzyme analysis Methods 0.000 description 1
210000002745 epiphysis Anatomy 0.000 description 1
YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
229960000403 etanercept Drugs 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
229960005420 etoposide Drugs 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000005713 exacerbation Effects 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000000284 extract Substances 0.000 description 1
230000001815 facial effect Effects 0.000 description 1
208000033961 familial 2 hyperinsulinemic hypoglycemia Diseases 0.000 description 1
201000001386 familial hypercholesterolemia Diseases 0.000 description 1
208000019298 familial intrahepatic cholestasis Diseases 0.000 description 1
201000011110 familial lipoprotein lipase deficiency Diseases 0.000 description 1
208000015700 familial long QT syndrome Diseases 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
230000035558 fertility Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
210000004905 finger nail Anatomy 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
239000006260 foam Substances 0.000 description 1
102000035175 foldases Human genes 0.000 description 1
108091005749 foldases Proteins 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000020932 food allergy Nutrition 0.000 description 1
239000012595 freezing medium Substances 0.000 description 1
201000008049 fucosidosis Diseases 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
201000006440 gangliosidosis Diseases 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
108091008053 gene clusters Proteins 0.000 description 1
238000012224 gene deletion Methods 0.000 description 1
230000004545 gene duplication Effects 0.000 description 1
238000003209 gene knockout Methods 0.000 description 1
238000003208 gene overexpression Methods 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
210000004392 genitalia Anatomy 0.000 description 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
229960004666 glucagon Drugs 0.000 description 1
102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
230000009643 growth defect Effects 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000003862 health status Effects 0.000 description 1
230000010370 hearing loss Effects 0.000 description 1
231100000888 hearing loss Toxicity 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
201000011066 hemangioma Diseases 0.000 description 1
208000035861 hematochezia Diseases 0.000 description 1
230000002489 hematologic effect Effects 0.000 description 1
231100000753 hepatic injury Toxicity 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
208000009601 hereditary spherocytosis Diseases 0.000 description 1
208000013746 hereditary thrombophilia due to congenital protein C deficiency Diseases 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
102000044890 human EPO Human genes 0.000 description 1
102000043404 human GLA Human genes 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
230000003225 hyperhomocysteinemia Effects 0.000 description 1
230000006951 hyperphosphorylation Effects 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000036031 hyperthermia Effects 0.000 description 1
208000003532 hypothyroidism Diseases 0.000 description 1
229960001101 ifosfamide Drugs 0.000 description 1
HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000017745 inborn carbohydrate metabolic disease Diseases 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000004968 inflammatory condition Effects 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
229960000598 infliximab Drugs 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
230000005865 ionizing radiation Effects 0.000 description 1
230000007803 itching Effects 0.000 description 1
210000001503 joint Anatomy 0.000 description 1
230000008407 joint function Effects 0.000 description 1
208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
201000010982 kidney cancer Diseases 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
239000006390 lc 2 Substances 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
208000036546 leukodystrophy Diseases 0.000 description 1
108010052968 leupeptin Proteins 0.000 description 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
239000003446 ligand Substances 0.000 description 1
238000004811 liquid chromatography Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
201000007270 liver cancer Diseases 0.000 description 1
208000014018 liver neoplasm Diseases 0.000 description 1
244000144972 livestock Species 0.000 description 1
230000004807 localization Effects 0.000 description 1
208000019017 loss of appetite Diseases 0.000 description 1
235000021266 loss of appetite Nutrition 0.000 description 1
208000012866 low blood pressure Diseases 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
230000005980 lung dysfunction Effects 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
210000004324 lymphatic system Anatomy 0.000 description 1
230000000527 lymphocytic effect Effects 0.000 description 1
101150109301 lys2 gene Proteins 0.000 description 1
210000003712 lysosome Anatomy 0.000 description 1
230000001868 lysosomic effect Effects 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
208000002780 macular degeneration Diseases 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
150000008146 mannosides Chemical class 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
208000008585 mastocytosis Diseases 0.000 description 1
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 description 1
229960004961 mechlorethamine Drugs 0.000 description 1
HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
210000001006 meconium Anatomy 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
229960001924 melphalan Drugs 0.000 description 1
SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
230000006677 mitochondrial metabolism Effects 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
208000005907 mitral valve insufficiency Diseases 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
229940051875 mucins Drugs 0.000 description 1
201000007769 mucolipidosis Diseases 0.000 description 1
208000020460 mucolipidosis II alpha/beta Diseases 0.000 description 1
230000003843 mucus production Effects 0.000 description 1
208000015325 multicentric Castleman disease Diseases 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
HNQXDLYBFNWFEE-VHZSLYHRSA-N n-[(2r,3r,4r,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-5-[(2r,3s,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-1-oxo-4-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] Chemical compound O([C@H]([C@H](C=O)NC(=O)C)[C@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H](CO[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1[C@H]([C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O[C@@H]1[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O HNQXDLYBFNWFEE-VHZSLYHRSA-N 0.000 description 1
239000006225 natural substrate Substances 0.000 description 1
201000008383 nephritis Diseases 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
201000005119 neurohypophyseal diabetes insipidus Diseases 0.000 description 1
201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 1
201000001119 neuropathy Diseases 0.000 description 1
230000007823 neuropathy Effects 0.000 description 1
210000002445 nipple Anatomy 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
OSTGTTZJOCZWJG-UHFFFAOYSA-N nitrosourea Chemical compound NC(=O)N=NO OSTGTTZJOCZWJG-UHFFFAOYSA-N 0.000 description 1
201000010854 nut allergy Diseases 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
208000012144 orthopnea Diseases 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
101150026679 ost5 gene Proteins 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
229960001592 paclitaxel Drugs 0.000 description 1
229940124583 pain medication Drugs 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
150000002960 penicillins Chemical class 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
206010034674 peritonitis Diseases 0.000 description 1
210000002824 peroxisome Anatomy 0.000 description 1
238000001050 pharmacotherapy Methods 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
239000006187 pill Substances 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
229960001237 podophyllotoxin Drugs 0.000 description 1
YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
208000030428 polyarticular arthritis Diseases 0.000 description 1
229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920002704 polyhistidine Polymers 0.000 description 1
208000005987 polymyositis Diseases 0.000 description 1
230000007824 polyneuropathy Effects 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
208000013846 primary aldosteronism Diseases 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
201000009266 primary ciliary dyskinesia Diseases 0.000 description 1
229960000624 procarbazine Drugs 0.000 description 1
CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001915 proofreading effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
201000001474 proteinuria Diseases 0.000 description 1
208000005631 pseudoachondroplasia Diseases 0.000 description 1
235000021251 pulses Nutrition 0.000 description 1
230000004144 purine metabolism Effects 0.000 description 1
230000004147 pyrimidine metabolism Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000003156 radioimmunoprecipitation Methods 0.000 description 1
229910052704 radon Inorganic materials 0.000 description 1
SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
206010037844 rash Diseases 0.000 description 1
108700012830 rat Lip2 Proteins 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000008085 renal dysfunction Effects 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000016914 response to endoplasmic reticulum stress Effects 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
206010039083 rhinitis Diseases 0.000 description 1
210000003935 rough endoplasmic reticulum Anatomy 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
206010039722 scoliosis Diseases 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
101150044914 sec59 gene Proteins 0.000 description 1
230000009962 secretion pathway Effects 0.000 description 1
230000035939 shock Effects 0.000 description 1
208000013220 shortness of breath Diseases 0.000 description 1
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
125000005629 sialic acid group Chemical group 0.000 description 1
208000027128 sialidosis type 1 Diseases 0.000 description 1
201000009890 sinusitis Diseases 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
230000037370 skin discoloration Effects 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
231100000046 skin rash Toxicity 0.000 description 1
201000002859 sleep apnea Diseases 0.000 description 1
239000000779 smoke Substances 0.000 description 1
210000000783 smooth endoplasmic reticulum Anatomy 0.000 description 1
206010041232 sneezing Diseases 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011775 sodium fluoride Substances 0.000 description 1
235000013024 sodium fluoride Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
208000002320 spinal muscular atrophy Diseases 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
201000005671 spondyloarthropathy Diseases 0.000 description 1
208000005801 spondylosis Diseases 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000001694 spray drying Methods 0.000 description 1
230000037359 steroid metabolism Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
238000000756 surface-enhanced laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
229960001603 tamoxifen Drugs 0.000 description 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
208000009056 telangiectasis Diseases 0.000 description 1
206010043207 temporal arteritis Diseases 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
229960000814 tetanus toxoid Drugs 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
201000002510 thyroid cancer Diseases 0.000 description 1
238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
210000004906 toe nail Anatomy 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
108091006106 transcriptional activators Proteins 0.000 description 1
238000001890 transfection Methods 0.000 description 1
239000012096 transfection reagent Substances 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000011426 transformation method Methods 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000032258 transport Effects 0.000 description 1
102000040811 transporter activity Human genes 0.000 description 1
108091092194 transporter activity Proteins 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
201000002311 trypanosomiasis Diseases 0.000 description 1
208000009999 tuberous sclerosis Diseases 0.000 description 1
239000002451 tumor necrosis factor inhibitor Substances 0.000 description 1
102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
201000005112 urinary bladder cancer Diseases 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
206010046885 vaginal cancer Diseases 0.000 description 1
208000013139 vaginal neoplasm Diseases 0.000 description 1
LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
229960003048 vinblastine Drugs 0.000 description 1
JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
229960004528 vincristine Drugs 0.000 description 1
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
230000004393 visual impairment Effects 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
208000016261 weight loss Diseases 0.000 description 1
229910000166 zirconium phosphate Inorganic materials 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

JP2010501617A 2007-04-03 2008-04-03 分子のグリコシル化 Expired - Fee Related JP5967861B2 (ja)